Gateway effects and electronic cigarettes

Addiction

Volumn 113, Issue 10, 2018, Pages 1776-1783

  Etter, Jean François ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

E cigarette; electronic cigarette; gateway effect; gateway theory; nicotine; smoking; tobacco use disorder

Indexed keywords

CAUSALITY; CIGARETTE SMOKING; EPIDEMIOLOGY; HUMAN; PSYCHOLOGICAL THEORY; VAPING;

CAUSALITY; CIGARETTE SMOKING; HUMANS; PSYCHOLOGICAL THEORY; VAPING;

EID: 85027528027     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13924     Document Type: Article

References (56)

1. Bell K., Keane H. All gates lead to smoking: the ‘gateway theory’, e-cigarettes and the remaking of nicotine. Soc Sci Med 2014; 119: 45–52.
2. Kandel D. Stages in adolescent involvement in drug use. Science 1975; 190: 912–914.
3. Kandel D. B., Yamaguchi K., Klein L. C. Testing the gateway hypothesis. Addiction 2006; 101: 470–472. discussion 474–476.
4. Vanyukov M. M., Tarter R. E., Kirillova G. P., Kirisci L., Reynolds M. D., Kreek M. J. et al. Common liability to addiction and ‘gateway hypothesis’: theoretical, empirical and evolutionary perspective. Drug Alcohol Depend 2012; 123: S3–17.
5. Hall W. D., Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 2005; 24: 39–48.
6. Maccoun R. J. In what sense (if any) is marijuana a gateway drug? FAS Drug Policy Analysis Bull 19984: 5–4: 8.
7. European Union (EU). Directive 2014/40/EU of the European Parliament and of the council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the member states concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. Off J Eur Union 2014 L 127.
8. Arrazola R. A., Singh T., Corey C. G., Husten C. G., Neff L. J., Apelberg G. A. et al. Tobacco use among middle and high school students—United States, 2011–2014. Morb Mort Wkly Rep 2015381–385.
9. Warner K. E. Frequency of E-cigarette use and cigarette smoking by American students in 2014. Am J Prev Med 2016; 51: 179–184.
10. Saddleson M. L., Kozlowski L. T., Giovino G. A., Homish G. G., Mahoney M. C., Goniewicz M. L. Assessing 30-day quantity-frequency of U.S. adolescent cigarette smoking as a predictor of adult smoking 14 years later. Drug Alcohol Depend 2016; 162: 92–98.
11. Brener N. D., Billy J. O., Grady W. R. Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature. J Adolesc Health 2003; 33: 436–457.
12. Lee P. N. Appropriate and inappropriate methods for investigating the ‘gateway’ hypothesis, with a review of the evidence linking prior snus use to later cigarette smoking. Harm Reduct J 2015; 12: 8.
13. Morral A. R., McCaffrey D. F., Paddock S. M. Reassessing the marijuana gateway effect. Addiction 2002; 97: 1493–1504.
14. Hill A. B. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300.
15. Royal College of Physicians (RCP). Nicotine without smoke: tobacco harm reduction. London: RCP; 2016.
16. Farsalinos K. E., Poulas K., Voudris V., Le Houezec J. Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey. Intern Emerg Med 2017; https://doi.org/10.1007/s11739-017-1643-7.
17. Geckova A., van Dijk J. P., van Ittersum-Gritter T., Groothoff J. W., Post D. Determinants of adolescents’ smoking behaviour: a literature review. Cent Eur J Public Health 2002; 10: 79–87.
18. Etter J. F. Smoking and Cloninger's temperament and character inventory. Nicotine Tob Res 2010; 12: 919–926.
19. Batra V., Patkar A. A., Berrettini W. H., Weinstein S. P., Leone F. T. The genetic determinants of smoking. Chest 2003; 123: 1730–1739.
20. Phillips C. V. Gateway effects: why the cited evidence does not support their existence for low-risk tobacco products (and what evidence would). Int J Environ Res Public Health 2015; 12: 5439–5464.
21. Eastwood B., Dockrell M. J., Arnott D., Britton J., Cheeseman H., Jarvis M. J. et al. Electronic cigarette use in young people in great Britain 2013–2014. Public Health 2015; 129: 1150–1156.
22. King C. 3rd, Siegel M., Celebucki C., Connolly G. N. Adolescent exposure to cigarette advertising in magazines: an evaluation of brand-specific advertising in relation to youth readership. JAMA 1998; 279: 516–520.
23. Fowler J. S., Logan J., Wang G. J., Volkow N. D. Monoamine oxidase and cigarette smoking. Neurotoxicology 2003; 24: 75–82.
24. Etter J. F., Eissenberg T. Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes. Drug Alcohol Depend 2015; 147: 68–75.
25. Liu G., Wasserman E., Kong L., Foulds J. A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study. Prev Med 2017; https://doi.org/10.1016/j.ypmed.2017.04.001.
26. St Helen G., Havel C., Dempsey D. A., Jacob P. III, Benowitz N. L. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 2016; 111: 535–544.
27. Etter J. F., Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011; 106: 2017–2028.
28. Centers for Disease Control and Prevention (CDC). Trends in the prevalence of tobacco use National YRBS: 1991–2015 Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; 2016.
29. Action on Smoking and Health (ASH). Smoking statistics, who smokes and how much, action on smoking and health fact sheet. London, UK: ASH; 2016.
30. Pesko M. F., Hughes J. M., Faisal F. S. The influence of electronic cigarette age purchasing restrictions on adolescent tobacco and marijuana use. Prev Med 2016; 87: 207–212.
31. Friedman A. S. How does electronic cigarette access affect adolescent smoking? J Health Econ 2015; 44: 300–308.
32. Pesko M., Currie J. The effect of e-cigarette minimum legal sale age laws on traditional cigarette use and birth outcomes among pregnant teenagers, National Bureau of Economic Research (NBER) Working Paper 2016: Paper no. 22792. Cambridge, MA: NBER; 2016.
33. Ponzoni L., Moretti M., Sala M., Fasoli F., Mucchietto V., Lucini V. et al. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur Neuropsychopharmacol 2015; 25: 1775–1786.
34. LeSage M. G., Staley M., Muelken P., Smethells J. R., Stepanov I., Vogel R. I. et al. Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats. Drug Alcohol Depend 2016; 168: 76–88.
35. Etter J. F. Addiction to the nicotine gum in never smokers. BMC Public Health 2007; 7: 159.
36. Shiffman S., Sweeney C. T. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability? Health Policy 2008; 86: 17–26.
37. Fant R. V., Henningfield J. E., Nelson R. A., Pickworth W. B. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control 1999; 8: 387–392.
38. Hatsukami D. K., Gust S. W., Keenan R. M. Physiologic and subjective changes from smokeless tobacco withdrawal. Clin Pharmacol Ther 1987; 41: 103–107.
39. Norberg M., Malmberg G., Ng N., Brostrom G. Who is using snus?—time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population. BMC Public Health 2011; 11: 929.
40. Timberlake D. S., Huh J., Lakon C. M. Use of propensity score matching in evaluating smokeless tobacco as a gateway to smoking. Nicotine Tob Res 2009; 11: 455–462.
41. Lee P. N. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011; 59: 197–214.
42. Lund I., Lund K. E. How has the availability of snus influenced cigarette smoking in Norway? Int J Environ Res Public Health 2014; 11: 11705–11717.
43. Foulds J., Ramstrom L., Burke M., Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003; 12: 349–359.
44. Le Houezec J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int J Tuberc Lung Dis 2003; 7: 811–819.
45. Schneider N. G., Olmstead R. E., Franzon M. A., Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 2001; 40: 661–684.
46. Levy D. T., Cummings K. M., Villanti A. C., Niaura R., Abrams D. B., Fong G. T. et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction 2017; 112: 8–17.
47. McRobbie H., Bullen C., Hartmann-Boyce J., Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014; Issue 12. Art. No.: CD010216. https://doi.org/10.1002/14651858.CD010216.pub2.
48. Adriaens K., Van Gucht D., Declerck P., Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 2014; 11: 11220–11248.
49. Brose L. S., Hitchman S. C., Brown J., West R., McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 2015; 110: 1160–1168.
50. Stead L. F., Perera R., Bullen C., Mant D., Hartmann-Boyce J., Cahill K. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; Issue 11. Art. No.: CD000146. https://doi.org/10.1002/14651858.CD000146.pub4.
51. Malas M., van der Tempel J., Schwartz R., Minichiello A., Lightfoot C., Noormohamed A. et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine Tob Res 2016; 18: 1926–1936.
52. Hamilton H. A., Ferrence R., Boak A., Schwartz R., Mann R. E., O'Connor S. et al. Ever use of nicotine and nonnicotine electronic cigarettes among high school students in Ontario. Canada. Nicotine Tob Res 2015; 17: 1212–1218.
53. Morean M. E., Kong G., Cavallo D. A., Camenga D. R., Krishnan-Sarin S. Nicotine concentration of e-cigarettes used by adolescents. Drug Alcohol Depend 2016; 167: 224–227.
54. Primack B. A., Soneji S., Stoolmiller M., Fine M. J., Sargent J. D. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr 2015; 169: 1018–1023.
55. Barrington-Trimis J. L., Urman R., Berhane K., Unger J. B., Cruz T. B., Pentz M. A. et al. E-cigarettes and future cigarette use. Pediatrics 2016; 138: pii: e20160379. doi: https://doi.org/10.1542/peds.2016-0379.
56. Leventhal A. M., Stone M. D., Andrabi N., Barrington-Trimis J., Strong D. R., Sussman S. et al. Association of e-cigarette vaping and progression to heavier patterns of cigarette smoking. JAMA 2016; 316: 1918–1920.